CD15+LOX-1+ PMN-MDSC frequency is increased in PB of NSCLC patients
To compare the CD15+LOX-1+ PMN-MDSC frequency in NSCLC patients with that in healthy donors, we detected the proportion of CD15+LOX-1+ PMN-MDSCs in PB of the two groups. Detailed information of NSCLC patients were listed in Table 1. Based on the results of FCM, it was indicated that CD15+LOX-1+ PMN-MDSC frequency was significantly up-regulated in the circulation of NSCLC patients (20.84±1.342 %) compared to healthy individuals (3.215±0.1346 %) (Figure 1, P <0.0001).